Product image of Byooviz (Ranibizumab) supplied by GNH India

Byooviz

Active Ingredient:
Ranibizumab
Origin:
EU

Byooviz (Ranibizumab)

Byooviz is a biologic medication used for intravitreal administration to treat certain eye conditions. It contains ranibizumab, a protein designed to inhibit vascular endothelial growth factor (VEGF).

Manufacturer / TM Owner

Samsung Bioepis Nl B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Byooviz is primarily used for the treatment of neovascular (wet) age-related macular degeneration (AMD), a condition that can lead to vision loss. It may also be used for other eye conditions involving abnormal blood vessel growth. Byooviz works by blocking VEGF, which can help reduce swelling and prevent further damage to the retina.

Side Effects

  • Byooviz is designed to target and inhibit VEGF, which can help reduce abnormal blood vessel growth in the eye. This may lead to improved vision or stabilization of vision in certain eye conditions. Common effects may include reduced retinal swelling and improved retinal function.

Precautions & Warnings

  • Byooviz should be administered by a healthcare professional experienced in intravitreal injections. It is important to follow all safety guidelines and monitor for any signs of infection or inflammation. Patients should discuss any pre-existing conditions or allergies with their healthcare provider before treatment.

Avoid Interactions

  • Byooviz may interact with other medications, particularly those that affect the immune system or blood vessels. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements may also interact with Byooviz, so it is advisable to discuss these with your healthcare provider.

Frequently Asked Questions

Byooviz is used to treat certain eye conditions, primarily neovascular (wet) age-related macular degeneration (AMD).

Byooviz is administered via intravitreal injection, which is performed by a healthcare professional.

Common effects of Byooviz may include reduced retinal swelling and improved retinal function, which can help stabilize or improve vision.

Yes, Byooviz should be administered by a healthcare professional, and patients should monitor for signs of infection or inflammation.

Yes, Byooviz may interact with other medications, particularly those that affect the immune system or blood vessels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ranibizumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT